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ASSOCIATED DIARRHEA DUE TO HYPERVIRULENT 
STRAIN NAP1/B1/027 IN A DEVELOPING COUNTRY
 
 
Monge Bonilla, Cecilia1; Acuña Feoli, Jos
Luis1; Jara Cordero, Olman1; Alvarado Aguilar, Marco
1 Médico Especialista en Medicina Interna. Departamento de Medicina Interna.  Sección de Medicina 4. Hospital San Juan de 
Dios. San José, Costa Rica. 
 
Resumen:  Los brotes nosocomiales de las cepas hipervirulenta de 
importante de salud pública debido a la naturaleza altamente contagiosa y letal de esta enfermedad en el 
ámbito intra-hospitalario.  Afortunadamente, estos casos son raros.  Presentamos el reporte y manejo de un 
brote nosocomial de C. difficile por una cepa hipervirulenta en un país en vías de desarrollo.  Entre mayo y 
agosto 2009, 81 casos de diarrea asociada a 
Hospital San Juan de Dios en Costa Rica.  El porcentaje de recu
uso de antibióticos, severidad del cuadro diarreico, recuento leucocitario y co
una alta recurrencia de la enfermedad.  Pacientes portadores de insuficiencia cardiaca congestiva, aq
recibiendo  inhibidores de bomba de protones o requiriendo vasopresores durante su hospitalización, 
presentaron un mayor riesgo de muerte.  La edad influenció la duración del cuadro diarreico.  La duración 
también aumentó con el uso de probióticos y
infecciosas no deben  ser más letales en un país  en vías de desarrollo. Una respuesta rápida y rigorosa y 
tratamientos costo efectivos son más relevantes que el acceso a una infraestructura compl
soporte avanzados. 
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Abstract:  Nosocomial outbreaks of hypervi
problem because of the highly infectious and lethal nature of the disease in a hospital environment. 
Fortunately, they are relatively rare. We provide a report of a 
management in a developing country.  From May to August 2009, 81 cases of 
(CDAD) were treated in an isolation unit at San Juan de Dios Hospital in Costa Rica. The recurrence rate was 
13.6% and the mortality rate was 9.9%. Antibiotic use, severity of CDAD, and leukocyte count were 
associated with higher recurrence rates of disease. The number of co
higher rate of recurrence. Patients with chronic heart failure, th
inhibitors, and those requiring vasopressor treatment during their hospitalization had a higher likelihood of 
dying. Age influenced the duration of diarrhea. The use of probiotics and vasopressors increased the amou
of days with diarrhea.  Outbreaks of CDAD and other infectious diseases do not need to be more lethal in a 
developing country. A rigorous and prompt response and cost
access to complex infrastructure or advanc
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INTRODUCTION  
 Clostridium difficile (C. difficile) is a Gram
positive endospore-forming bacillus capable of 
causing abdominal cramps, mild to severe 
diarrhea, and colitis. It is highly transmissible 
through the fecal–oral route and can be cultured 
from clothing, hands, health care equipmen
other surfaces [1,2,3]. Since the year 2000, the 
hypervirulent C difficile strain known as 
NAP1/B1/027 (i.e., North American pulsed
type I, restriction endonuclease analysis group B1, 
PCR ribotype 027) has been identified as the 
causative agent of C. difficile-associated diarrhea 
(CDAD) outbreaks within hospitals in develo
countries [3,4,5].  The NAP1/B1/027 strain differs 
from other C. difficile strains in several ways: it is 
resistant to fluoroquinolones in vitro, it is capable 
of producing a unique binary toxin, and it produces 
significantly greater amounts of exotoxi
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ns A and B 
in vitro and for prolonged periods of time
NAP1/B1/027 causes CDAD following colonization 
of the intestinal tract, facilitated by the disruption 
of normal intestinal flora due to antimicrobial 
therapy, among other factors. The 
exotoxins bind to receptors on intestinal epithelial 
cells, leading to inflammation and diarrhea
NAP1/B1/027 causes 
than other C. difficile strains, is more ref
standard therapy, is more likely to relapse, and, in 
developed countries, relapses at rates up to 30% 
which results in 16–20% mortality
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METHODS 
 Nosocomial CDAD cases were classified 
based on acute diarrhea and positive ELISA for 
exotoxin A in stool. High-risk pati
symptoms suggestive of CDAD were also admitted 
to the CDAD isolation unit. Patient data 
upon admission to the unit included information 
on risk factors and co-morbidities. All stool 
samples of patients in the isolation unit were 
tested for exotoxin A by ELISA. Proportions and 
exact binomial confidence limits were used to 
assess associations of patients’ characteristics with 
recurrence of diarrhea and discharge outcome. 
 Fisher’s exact test assessed statistical 
significance of the associations accounting for the 
small numbers in some of the groups.  
 Single and multivariate linear models 
estimated the effects of individual or medical 
history characteristics on the duration of diarrhea. 
 
CDAD patient management 
 A management protocol was developed by 
the attending internal medicine physicians 
coordinating the unit, with approval from the 
chairman of medicine and the head of the hospital.  
This management protocol ensured that medical 
care and treatment of CDAD patients was uniform. 
The protocol included criteria for diagnosis (Figure 
1), admission (Figure 2), transfer and discharge
(Figure 3), definition of severity, and treatment 
(Table 1). 
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Figure 1. Algorithm for the Diagnosis of 
difficile-associated diarrhea
 
 
 
 
A laboratory-based alert system was 
instituted. When a stool sample tested positive for 
C. difficile, the head nurse of the unit was notified 
so appropriate action could be taken. All hospital
personnel were educated on 
mechanisms of transmission, and the existence of 
the new isolation unit. 
 
 
Stool ELISA for 
toxin A
Positive in 
any sample
Continue 
treatment as 
started 
Clinical 
suspicion of 
CDAD
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Figure 2. Protocol for Patient Management of 
Isolation Unit in Hospital San Juan de Dios  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An eligible case for admission to the unit was 
defined as any patient with acute diarrhea 
positive ELISA for toxin A in stool.
High risk patients with a clinical presentation 
suggestive of CDAD were treated empirically 
even in the absence of a positive stool ELISA 
for toxin A. If the stool ELISA for toxin A 
remained negative, other diagnostic 
possibilities were evaluated. 
Patients considered at high risk 
include: 
 
Patients taking the following 
medications: 
-Antibiotics (especially the 
combination of a cephalosporin 
and a fluoroquinolone) 
-Proton pump inhibitors 
-Valacyclovir 
 
Patients with the following 
characteristics: 
-Inflammatory bowel disease                     
-Multiple or severe 
comorbidities 
-Advanced age (over 65) 
-Immunocompromised or in 
peripartum 
 
Environment:       
       -Prolonged hospital stay        
Laboratory results:                                      
.   Tel: (506) 25-11 4492, Fax: 25-11
C. difficile 
 
Figure 3. Transfer and Discharge Criteria
 
 
Resolution Criteria  for Transfer out of 
Unit in a First Episode:                                                       
1. Complete resolution of diarrhea 
(less than 3 bowel movements in 
24 hrs for 72 hrs) 
2. Afebrile for 48 hours
3. Decrease in leucocytosis
4. Absence of clinical signs of pseudo 
membranous colitis
*ELISA for toxin A in stool sample 
was not a requirement.
Resolution Criteria for Transfer out of  Unit in 
a Recurrence: Complete resolution of 
diarrhea 
Criteria that Prompt the Need for 
of Emergency Colectomy: 
1-Toxic megacolon 
2-Shock needing vasopressors or multiple 
organ failure 
Criteria for Discharge to Home:
1-Afebrile for 48 hours 
2-Complete resolution of diarrhea
3-Improvement in leucocytosis
4-Tolerating oral route 
5-Diagnosis for hospital admission 
resolved or improved 
    * Negative ELISA for toxin was not a 
criteria for discharge. 
 
and 
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Table 1.  Treatment Protocols for CDAD Based on the 
Severity of Clinical Presentation 
 
 
Definition Treatment Severity
All cases that are 
not severe 
Metronidazole 
500 mg PO q6 
hours for 14 days 
Mild 
 
ICU cases or with 2 
of the following : 
>60 yrs old,  
temp.>38.4°C , 
leucocytes >15,000 
10–3/mm3 or 
albumin  <2.5 g/dL. 
 
 
Vancomycin 500 
mg PO q6 hours 
for 14 days 
 
Severe 
Treatment failure 
after 3 days or 
progression to 
ileum, toxic 
megacolon, septic 
shock, marked 
leucocytosis, 
hypotension, or 
anasarca 
Vancomycin 500 
mg PO q 6 hours 
for 14 days 
PLUS 
Metronidazole 
500 mg IV q 6 
hours for 14 days 
 
Refractory 
or 
fulminant 
CDAD 
Symptomatic 
recurrence after 
treatment regimen 
and resolution of 
first episode  
Reclassified as 
per severity and 
treated 
accordingly  
First 
recurrence
Symptomatic 
recurrence after  
treatment regimen 
and resolution of 
first recurrence 
Vancomycin PO 
125 mg q6 hours 
for 14 days, 125 
mg q 12 hours for 
7 days, 125 mg 
QD for 7 days, 
125 mg q 48 
hours for 8 days 
(4 doses) and 125 
mg q 72 hours for 
15 days (5 doses) 
 
Second 
recurrence
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Response 
Rate 
 
90% 
 
 
97% 
 
 
No data 
 
 
 
No data 
 
 
 
86% 
 A data recollection sheet was used for every 
admission to the C. difficile
information included; name, gender, date of birth, 
date of admission to the hospital and to the unit, 
length of stay, length and severity of disease, 
service or ward from where patient was 
transferred, admission diagnosis, co
medications prior and during admission and 
hospitalizations in the prior three months, use of 
antibiotics currently and in the last three months, 
outcome, and recurrences.
 There were 12–
consisting of six beds per room. Patients were 
assigned to a room according to gender, and each 
group of six patients shared common bathrooms, 
showers, and hand wash bins.
 The CDAD isolation unit was cohort nurs
together. The nursing personnel played a vital role 
in the correct and optimal functioning of the unit 
and did not rotate out of the unit. They did not 
leave the unit throughout their shift; food was 
brought to them from the nutrition department.  A 
strict log of number of stools was recorded in 
addition to vital signs and other typical 
information. 
 Visitors were prohibited in the unit except 
under extraordinary circumstances and were 
limited to five minutes. Medical students were not 
allowed. 
 Methods for contact precaution included
strict hand hygiene protocols with soap and water. 
Alcohol-based solutions were not used.  Health 
care workers and support personnel who came in 
contact with the isolated p
adhere strictly to antiseptic 
posters displayed the correct method
washing. 
A changing station was installed at the entrance of 
the unit where personnel would change into green 
2011 
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-morbidities, 
 
24 beds in the isolation unit 
 
ed 
 
atients were urged to 
measures.  Educational 
 for hand 
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scrubs, hats, and boots.  There was a security guard 
at the entrance of the unit during all hospital shifts 
to ensure the adherence of these measures and to 
keep a log of personnel who entered and exited the 
unit. 
 Prior to health care workers entering the 
patient rooms, they would wear disposable gowns 
(on top of the green scrubs), masks, and gloves; 
these were used during examination or contact 
with each individual patient and disposed of after 
being used with each patient. 
 Equipment used for patient care, such as 
stethoscopes, thermometers, and blood pressure 
cuffs, were thoroughly cleaned between uses, since 
disposable medical equipment was unavailable.
 An integrated infection control program 
included a strict cleaning schedule every 4 hours 
with dilute bleach (10% sodium hypochlorite)
surfaces, beds, mattresses, tables, walls, and 
windows were cleaned to eliminate 
spores, which can remain on surfaces for up to 
three months [3,13,15]. 
 An antibiotic control program limiting the 
use of broad-spectrum antibiotics, restricting IV 
antibiotics, and using short duration treatment 
protocols was developed by the infectious disease 
department to try to decrease the pool of 
susceptible patients. 
Statistical methods 
 Within the patients treated in the 
isolation unit from May to August we studied the 
association of patient’s characteristics and medical 
history with recurrence of CDAD, outcome (death, 
discharge or transfer) and days to resolution of 
diarrhea. 
 A total of 81 patients were admitted to the 
C. difficile isolation unit in the months of May, June, 
.   Tel: (506) 25-11 4492, Fax: 25-11
 
. All 
C. difficile 
C. difficile 
July, and August 2009.  43 patients were female 
and 37 male.  The mean age of the patient 
population was 62 years old with a range of 13
years. The mean day to resolution of diarrhea was 
5 with a range of 1–17 days. A total of 8 of the 81 
patients died (9.9% mortality). The recurrence rate 
observed was 13.6% (11 patients recurred at least 
once). 
 We used proportions and exact binomial 
confidence limits to assess associations of patients’ 
characteristics with recurrence of diarrhea and the 
outcome: transfer, discharge, or death. We were 
not able to perform multivariate modeling due to 
low numbers of patients with adverse outcomes 
(recurrence or death). 
 Fisher’s exact test was used to assess 
statistical significance of the associations
accounting for the small numbers in some of the 
groups.  
 Single and multivariate linear models 
estimated the effects of individual (age, sex) or 
medical history characteristics (use of antibiotics 
and other medications, presence of comorbidities, 
leukocyte count, serum albumin level and severity 
of diarrhea) on duration of diarrhea. Analysis of 
residuals assessed the validity of assumptions of 
the model: linearity of relationships, 
heteroscedasticity and normality 
dependent variable is skewed and represents 
counts, we used log-days as the outcome 
models. The most parsimonious model was 
determined using Wald tests of regression 
coefficients and Akaike Information Criterion 
(AIC), a measure of goodness of fit that penalizes 
for including additional predictors in the model. 
Lowess non-parametri
assess the functional form of age
spline with the appropriate knot was used to 
account for the non
exploratory analyses [16,17
2011 
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[14]. Since the 
in all 
c smoother was used to 
 [16].  Linear 
-linearity observed in the 
]. 
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 Reported estimates are based on all 
available values on the variables with missing data 
(complete case analyses). Additionally, assuming 
that values of the predictors are missing at 
random, multiple imputation of missing data was 
performed. MCMC data augmentation method was 
applied using other available measures, to i
the missing values [18].  Sensitivity of results to 
the model specifications was assessed by including 
various sets of variables in the imputation models. 
 Stata 10 (StataCorp. 2007. Stata Statistical 
Software: Release 10. College Station, TX: 
StataCorp LP) was used for the analyses and SAS 
version 9.2 for Windows (SAS Institute, Cary, North 
Carolina) was used for multiple imputations of 
missing values and for combining the parameter 
estimates. 
 
RESULTS 
 An increased incidence and associated 
mortality of CDAD was reported in the internal 
medicine wards of the Hospital San Juan de Dios 
during March and April 2009. Samples were sent to 
the National Microbiology Laboratory of the 
Canadian Agency for Public Health. The 
strain NAP1 was identified, containing enhanced 
genes for exotoxins A and B, the binary toxin gene, 
and deletion of the regulatory gene tcdC
 A dedicated C. difficile isolation unit was 
established promptly to manage this nosocomial 
outbreak. In May 2009—the first month of
CDAD unit— the vast majority of patients were 
transferred to the unit after having been in the 
hospital for at least 72 hours, indicating that they 
were infected after they arrived in the hospital. 
Over the next three months, 12 patients that had 
been released from the unit were re-
August 2009 some CDAD patients were admitted 
.   Tel: (506) 25-11 4492, Fax: 25-11
mpute 
 
C. difficile 
. 
 the 
admitted. In 
directly from the community, rather than from 
other parts of the hospital. It was not possible to 
determine whether these latter patients were 
exposed to CDAD patient
discharged from the hospital, because
epidemiological follow
done, due to lack of funding. 
 Within the CDAD unit, management 
practices and patient care were standardized. For 
statistical purposes, these can be co
fixed variables. Details of these practices are 
described in the Methods.
 Statistical analyses were performed to 
evaluate the clinical course of CDAD within the 
isolation unit in relation to various risk factors. 
Table 2 details the relationships of various factors 
and the recurrence of diarrhea. In the univariate 
analyses, antibiotic use, leukocyte count, and 
severity of diarrhea were significantly associated 
with recurrence of diarrhea. Among patients who 
reported antibiotic use within the previous three 
months, 21% had recurrence of diarrhea (95% CI 
11–36) compared to only 6% 
antibiotic use (95% CI 1
= 0.064. Current antibiotic use was also predictive 
of recurrence: 23% (95% CI 11
(95% CI 1–18) in non-
= 0.056.  
None of the reported co
as diabetes mellitus, high blood pressure, chronic 
obstructive pulmonary disease, congestive heart 
failure, or chronic kidney disease, were associated 
with recurrence in the univariate analyses
The number of co-morbidities, however, was 
related to recurrence of diarrhea. Twenty
percent of patients with multiple co
recurred (95% CI 11–
(1 patient out of 7) with no co
recurrence; Fisher’s exact p
2011 
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s that had been 
 
-up after discharge was not 
 
nsidered as 
 
of those without 
–20), Fisher’s exact p-value 
–38) versus 5% 
users, Fisher’s exact p-value 
-morbidities, such 
. 
-one 
-morbidities 
34), while fourteen percent 
-morbidities had a 
-value = 0.046.   
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Table 2.  Relationship of patient characteristics and the 
risk of recurrence of diarrhea 
 
 Recurrence  Total
 No (N=69) Yes 
(N=12) 
(N=81)
Gender, n (%)     
Female 38 (88%) 5 
(12%) 
Male 31 (84%) 6 
(16%) 
Missing 0 1 
Proton pump 
inhibitor , n (%) 
    
No 48 (87%) 7 
(13%) 
Yes 19 (83%) 4 
(17%) 
Missing 2 1 
Antibiotic use in 
last 3 months, n 
(%) 
    
No 32 (94%) 2 (6%) 
Yes 37 (79%) 10 
(21%) 
Current 
antibiotic use, n 
(%) 
    
No 35 (95%) 2 (5%) 
Yes 34 (77%) 10 
(23%) 
Cephalosporins , 
n (%) 
    
No 48 (86%) 8 
(14%) 
Yes 21 (84%) 4 
(16%) 
Quinolones , n 
(%) 
    
No 65 (88%) 9 
(12%) 
Yes 4 (57%) 3 
(43%) 
.   Tel: (506) 25-11 4492, Fax: 25-11
  
 P value 
  0.746* 
43   
37   
1   
  0.723* 
55   
23   
3   
0.064*  
34   
47   
  0.056* 
37   
44   
  1.000* 
56   
25   
  0.063* 
74   
7   
Penicillins , n 
(%) 
No 65 (87%)
Yes 4 (67%)
Clindamycin , n 
(%) 
No 66 (87%)
Yes 3 (60%)
Carbapenems , n 
(%) 
No 68 (87%)
Yes 1 (33%)
Aminoglycosides 
, n (%) 
No 65 
Yes 4 (80%)
Other , n (%) 
 
No 53 (95%)
Yes 16 (64%)
Comorbidity , n 
(%) 
No 6 (86%)
Yes 63 (85%)
Count of 
comorbidity , n 
(%) 
  
No 
comorbidity 
6 (86%)
One 
comorbidity 
21 (100%)
More than one 
comorbidity 
42 (79%)
2011 
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      0.215* 
 10 
(13%) 
75   
 2 
(33%) 
6   
      0.156* 
 10 
(13%) 
76   
 2 
(40%) 
5   
      0.056* 
 10 
(13%) 
78   
 2 
(67%) 
3   
      0.561* 
(86%) 11 
(14%) 
76   
 1 
(20%) 
5   
      0.001* 
 3 (5%) 56   
 9 
(36%) 
25   
      1.000* 
 1 
(14%) 
7   
 11 
(15%) 
74   
      
 1 
(14%) 
7   
 0 (0%) 21   
 11 
(21%) 
53   
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 Recurrence  Total
Diabetes 
mellitus, n (%) 
    
No 47 (89%) 6 
(11%) 
Yes 22 (79%) 6 
(21%) 
HTN, n (%)      
No 26 (93%) 2 (7%) 
Yes 43 (81%) 10 
(19%) 
Congestive heart 
failure, n (%) 
    
No 65 (86%) 11 
(14%) 
Yes 4 (80%) 1 
(20%) 
COPD, n (%)     
No 63 (85%) 11 
(15%) 
Yes 6 (86%) 1 
(14%) 
 
Missing 
0 1 
 No (N=69) Yes 
(N=12) 
(N=81)
Chronic kidney 
disease, n (%) 
    
No 59 (84%) 11 
(16%) 
Yes 10 (91%) 1 (9%) 
Use of 
probiotics, n (%) 
    
No 51 (81%) 12 
(19%) 
Yes 6 (100%) 0 (0%) 
Missing 12 0 
Immune 
suppression, n 
(%) 
    
No 60 85%) 11 
(15%) 
.   Tel: (506) 25-11 4492, Fax: 25-11
  
  0.324* 
53   
28   
  0.202* 
28   
53   
  0.561* 
76   
5   
  1.000* 
74   
7   
1   
 P value 
  1.000* 
70   
11   
  0.581* 
63   
6   
12   
  0.347* 
71   
Yes 9 (100%)
Missing 
Leukocyte count 
, n (%) 
<10,000 36 (97%)
>=10,000 33 (77%)
Missing 
Severity of 
CDAD, n (%) 
Mild 33 (92%)
Severe 28 (85%)
Fulminant 3 (100%)
Ileum or 
megacolon 
1 (100%)
Recurrence 3 (43%)
Missing 
Age (yrs) 
Mean (SD) 62 (19)
Range 
Days to 
resolution of 
fever 
Mean (SD) 3.8 (4.7)
Range 
Days to 
resolution of 
diarrhea 
  
Mean (SD) 4.7 (4.2)
Range 1-17 
 
SD= Standard deviation 
* Fisher's Exact test 
† F test 
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 0 (0%) 9   
0 1 1   
      0.009* 
 1 (3%) 37   
 10 
(23%) 
43   
0 1 1   
      0.041* 
 3 (8%) 36   
 5 
(15%) 
33   
 0 (0%) 3   
 0 (0%) 1   
 4 
(57%) 
7   
0 1 1   
      0.271† 
 68 (17) 63 (19)   
13-91 31-91 13-91   
   0.371† 
 2 (2) 3.3 (4.2)   
0-14 01-Jun 0-14   
    0.912† 
 4.8 
(4.2) 
4.7 (4.2)   
1-15 1-17   
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Greater leukocyte count was associated with 
higher probability of recurrence.  
Greater leukocyte count was associated with 
higher probability of recurrence. The proportion 
recurred among patients with leukocyte count of 
10,000 x 103/mm3 and above was 23% (95% CI 
12–39), while the same proportion among patients 
with a count of less than 10,000 103/mm
(95% CI 0.1–14), Fisher’s exact p-value = 0.009. 
 Severity of diarrhea was also predictive of 
future recurrence in univariate analyses. Fifteen 
percent of patients with severe CDAD had a 
recurrence (95% CI 5–32) compared to 8% of 
recurrence in patients with mild CDAD (95% CI 2
22), Fisher’s exact p-value = 0.04. 
 Table 3 associates patient characteristic
with the manner in which patients left the CDAD 
unit, what we call discharge outcome. Neither age 
nor gender was related to discharge outcome. 
Among the medical history characteristics we 
identified, congestive heart failure, use of proton 
pump inhibitors, and vasopressors were associated 
with higher probability of death.  
 Patients with congestive heart failure had 
significantly higher mortality: 2 out of 4 patients 
with congestive heart failure died, 50% (95% CI 7
93) compared to 8% among 77 patients without 
this co-morbidity (95% CI 3–16), Fisher’s exact p
value = 0.035.  
 Seventeen percent of patients in whom 
proton pump inhibitors were used died (95% CI 5
37) compared to 7% of patients who did not use 
this medication (95% CI 2–18), Fisher’s exact p
value = 0.032. The use of vasopressors was also 
associated with higher mortality: 43% versus 7% 
in non-users, 95% CI 10–82 and 2
respectively; p-value = 0.012.  
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3 was 3% 
 
–
 
–
-
–
-
–15, 
Table 4 summarizes the results of simple and 
multivariate linear regressions of the relationship 
between individual and medical history 
characteristics and the duration of diarrhea. The 
final model included patients’ age, use of 
antibiotics, probiotics, and vasopressors, degree of 
immune suppression, and leukocyte count. 
In univariate and multivariate analyses, we 
observed a change in the relationship of duration 
of diarrhea and patients’ age for older versus 
younger patients. Among otherwise similar 
patients age 40 and younger at admission, we 
estimate that on average, diarrhea lasts 3% shorter 
for patients one year older (95% CI 0
0.024). For patients above 40 years of age and 
having similar medical history characteristics, the 
diarrhea lasts on average 1% longer for every 1
year increase in age (95% CI 0
Use of antibiotics (cepha
with reduced duration of diarrhea in univariate 
and multivariate analyses. Among patients of the 
same age, same profile of probiotics and/or 
vasopressor usage, the same degree of immune 
suppression, and leukocyte count, the use of
antibiotics reduced the duration of diarrhea by an 
estimated 49% (95% CI 39
The use of probiotics and vasopressors, on 
the other hand, was associated with longer 
duration of diarrhea. In multivariate analyses, use 
of probiotics was associated with 2.6
duration of diarrhea in this patient population 
(95% CI 1.65–4.02, p-
were generally used in recurrent cases, which 
could well explain this finding. The use of 
vasopressors was associated with 3
duration of diarrhea (95% CI 2.1
0.0001). The use of vasopressors can be an 
indicator of septic shock implying increased 
severity of disease, which may explain this 
2011 
 
10 
-4489. 
 
–6, p-value = 
-
–2, p-value = 0.011).  
losporins) was associated 
 
–63, p-value < 0.0001). 
-times longer 
value < 0.0001). Probiotics 
-fold longer 
–4.5, p-value < 
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association. The model explained about 40% of the 
variability in duration of diarrhea in these patients.
 
Table 3. Relationships of patient characteristics with the 
outcome 
 
  
Outcome 
  
 Transfer 
(N=20) 
Discharge 
(N=52) 
Death 
(N=8) 
Gender, n (%)       
Female 10 (27%) 22 (59%)  
5(14%) 
Male 10 (23%) 30 (70%) 3 (7%) 
Missing 0 1 0 
Proton pump 
inhibitor , n (%) 
      
No 18 (33%) 32 (59%) 4 (7%) 
Yes 2 (8%) 18 (75%)  (17%) 
Missing 0 3 0 
Antibiotic use in 
last 3 months, n 
(%) 
      
No 6 (18%) 21 (64%) 6(18%) 
Yes 14 (29%) 32 (67%) 2 (4%) 
Current 
antibiotic use , n 
(%) 
      
No 11 (30%) 22 (59%) 4(11%) 
Yes 9 (20%) 31 (70%) 4 (9%) 
Cephalosporins , 
n (%) 
      
No 16 (28%) 37 (65%) 4 (7%) 
Yes 4 (17%) 16 (67%) 4(17%) 
Quinolones , n 
(%) 
      
No 16 (22%) 49 (67%) 8(11%) 
.   Tel: (506) 25-11 4492, Fax: 25-11
 
 
P values* 
Total 
(N=81) 
 0.547* 
37 
43 
1 
 0.035* 
54 
24 
3 
 0.100* 
33 
48 
0.584* 
37 
44 
 0.309* 
57 
24 
 0.236* 
73 
Yes 4 (50%) 
Penicillins , n 
(%) 
  
No 19 (25%) 
Yes 1 (17%) 
Clindamycin , n 
(%) 
  
No 20 (26%) 
Yes 0 (%) 
Carbapenems , n 
(%) 
  
No 19 (24%) 
Yes 1 (50%) 
Aminoglycosides 
, n (%) 
  
No 20 (26%) 
Yes 0 (0%) 
Other , n (%)   
No 16 (28%) 
Yes 4 (17%) 
 
SD= Standard deviation 
* Fisher's Exact test 
† F test 
 
 
 Due to missing data on leukocyte count, 
immune suppression,
probiotics, the final model included 68 out of a 
total of 81 subjects. After the data on missing 
predictors was imputed using a multiple 
imputation technique, the effects of antibiotics 
(cephalosporins) and use of probiotics remain
statistically significant with only slight attenuation 
of the regression coefficients towards the null. 
 
 
2011 
 
11 
-4489. 
4 (50%) 0 (0%) 8 
     1.000* 
48 (64%) 8(11%) 75 
5 (83%) 0 (0%) 6 
     0.451* 
48 (63%) 8(11%) 76 
5 (100%) 0 (0%) 5 
     0.575* 
52 (66%) 8(10%) 79 
1 (50%) 0 (0%) 2 
     0.339* 
49 (64%) 7 (9%) 76 
4 (80%) 1(20%) 5 
     0.287* 
34 (60%) 7(12%) 57 
19 (79%) 1 (4%) 24 
 vasopressors, and use of 
ed 
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Table 4. Results of simple and multivariate linear 
regressions estimating the relationship between 
patients’ characteristics and duration of diarr
 
Characteristic 
 
Unadjusted 
coefficients 
from 
simple 
linear 
models 
  
 Exponentiated 
Coefficient 
P-
value 
95% 
Confidence 
Interval 
Age: Slope for 
patients 40 
years of age 
and younger  
0.99 0.374 0.95 
Age: Slope for 
patients older 
than 40 
1.01 0.184 1.00 
Use of 
cephalosporins  
0.68 0.046 0.46 
Leukocyte 
count 10,000 
and greater 
1.39 0.086 0.95 
Use of 
probiotics 
3.10 0.001 1.61 
Use of 
vasopressors  
1.72 0.169 0.79 
Immune 
suppression  
1.10 0.754 0.59 
 Adjusted 
coefficients 
from 
multivariate 
linear model 
  
 Exponentiated 
Coefficient 
P-
value 
95% 
Confidence 
Interval 
Age: Slope for 
patients 40 
years of age 
and younger  
0.97 0.024 0.94 
Age: Slope for 
patients older 
than 40 
1.01 0.011 1.00 
Use of 
cephalosporins  
0.51 0.000 0.37 
Leukocyte 
count 10,000 
1.41 0.068 0.97 
.   Tel: (506) 25-11 4492, Fax: 25-11
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1.02 
1.02 
0.99 
2.02 
5.94 
3.72 
2.06 
 
 
1.00 
1.02 
0.71 
2.05 
and greater 
Use of 
probiotics 
2.58 
Use of 
vasopressors  
3.06 
Immune 
suppression  
1.61 
Number of 
observations 
68 
Model R-
Squared 
0.41 
 
 
 
Figure 4. Relationship between duration of diarrhea and 
age of patients 
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DISCUSSION  
 This is, to our knowledge, the first report of 
a nosocomial outbreak of hypervirulent CDAD in a 
developing country. Previous reports of 
nosocomial CDAD have been from developed 
countries.  However, given the increasing 
prevalence of CDAD globally, due to aging
populations and hospital crowding
frequency of these outbreaks may rise. Thus, an 
epidemiological study of the global spread of 
hypervirulent C. difficile may be warranted.
 This study was limited by available 
diagnostics. The only laboratory-
available in the hospital was ELISA for toxin A in 
stool. As a result, cases of CDAD not producing 
detectable levels of toxin A would have been 
missed. The study reports data for the first four 
months that the CDAD unit was in operation, 
although the unit operated beyond August 2009. 
The ability to collect data for longer periods of time 
and to include more patients could alter the results 
for overall mortality and recurrence, as well as 
impact the statistics on discharge outcome and 
duration of diarrhea.  
 It would have been informative to 
CDAD patients after they were discharged from the 
isolation unit and the hospital. This type of 
epidemiologic follow up should be part of all 
hypervirulent outbreak management protocols in 
order to follow and document trends and detect 
emergent ATB-resistant strains. This type of data 
recollection might prevent subsequent nosocomial 
and community outbreaks. 
 Despite these limitations, the management 
of this outbreak provides a model for managing 
similar outbreaks, especially in hospitals in 
locations with limited public health and healthcare 
resources. The integrated management and 
infection control program resulted in better than 
.   Tel: (506) 25-11 4492, Fax: 25-11
 
 [19], the 
 
based test 
follow 
average outcomes, indicating that outbreaks of this 
nature need not be more lethal in a developing 
country compared to a d
[20,21,22].   
 In conclusion, 
disease, a prompt and rigorous response, strict 
sterilization and containment, and cost
treatments are more important than access to 
complex infrastructure or advanced s
services. 
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